Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|July 26, 2005
Mixed exocrine-endocrine pancreatic carcinoma in childhoodC Ramachandra, Suraj Manjunath, Bindhu Joseph, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 25, 2012
The epigenetic silencing of the estrogen receptor (ER) by hypermethylation of the ESR1 promoter is seen predominantly in triple-negative breast cancers in Indian womenJyothi S Prabhu, Kanu Wahi, Aruna Korlimarla, et al.
Indian Journal of Surgical Oncology|May 27, 2017
Histological Surprises in Benign Cytologies after Lymph Node Biopsy-Surgeon's Knife Improving Patient CareMario Victor Newton, Rakesh S Ramesh, Suraj Manjunath, et al.
Indian Journal of Palliative Care|March 2, 2019
The Impact of Breast Cancer on the Patient and the Family in Indian PerspectiveAnnie Alexander, Rohini Kaluve, Jyothi S Prabhu, et al.
Indian Journal of Surgical Oncology|June 1, 2026
Total Neo-adjuvant Therapy [TNT] with Short Course Radiotherapy [SCRT] Followed by Total Mesorectal Excision [TME]-Sandwich Protocol in Locally Advanced Rectal Cancer [LARC]: a Prospective Observational Study in an Indian PopulationKarthik H K, Suraj Manjunath, Shabber Zaveri, et al.
Plos One|April 15, 2016
Identification of BRCA1 Deficiency Using Multi-Analyte Estimation of BRCA1 and Its Repressors in FFPE Tumor Samples from Patients with Triple Negative Breast CancerAruna Korlimarla, Jyothi S Prabhu, Jose Remacle, et al.
Journal of Cancer|February 25, 2014
A Majority of Low (1-10%) ER Positive Breast Cancers Behave Like Hormone Receptor Negative TumorsJyothi S Prabhu, Aruna Korlimarla, Krisha Desai, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 29, 2017
HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cellsKrisha Desai, Radhika Aiyappa, Jyothi S Prabhu, et al.
Translational Oncology|July 14, 2017
Dissecting the Biological Heterogeneity within Hormone Receptor Positive HER2 Negative Breast Cancer by Gene Expression Markers Identifies Indolent Tumors within Late Stage DiseaseJyothi S Prabhu, Aruna Korlimarla, C E Anupama, et al.
Cancer Medicine|May 18, 2016
High expression of integrin β6 in association with the Rho-Rac pathway identifies a poor prognostic subgroup within HER2 amplified breast cancersKrisha Desai, Madhumathy G Nair, Jyothi S Prabhu, et al.
Pageof 3